Evaluation of Hypertriglyceridemia in Critically Ill Patients With Coronavirus Disease 2019 Receiving Propofol

Eitemau Tebyg

• The Incidence of Propofol-Induced Hypertriglyceridemia and Identification of Associated Risk Factors
  gan: Corrado, Michael J., et al.
  Cyhoeddwyd: (2020)
• Evaluation of the Efficacy and Safety of Inhaled Epoprostenol and Inhaled Nitric Oxide for Refractory Hypoxemia in Patients With Coronavirus Disease 2019
  gan: DeGrado, Jeremy R., et al.
  Cyhoeddwyd: (2020)
• Propofol-Associated Hypertriglyceridemia in Coronavirus Disease 2019 Versus Noncoronavirus Disease 2019 Acute Respiratory Distress Syndrome
  gan: Kenes, Michael T., et al.
  Cyhoeddwyd: (2020)
• Renal Outcomes in Critically Ill Patients Receiving Propofol or Midazolam
  gan: Leite, Tacyano Tavares, et al.
  Cyhoeddwyd: (2015)
• Delirium Incidence, Duration, and Severity in Critically Ill Patients With Coronavirus Disease 2019
  gan: Khan, Sikandar H., et al.
  Cyhoeddwyd: (2020)